Keynote lecture: Mutation signatures and targeting the DNA damage response

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy

Liquid biopsy as a monitoring tool for the benefit of chemotherapy-immunotherapy in aNSCLC

Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer

Detecting copy number alterations using a pre-natal test

Comment: Radiotherapy as a treatment option for metastatic prostate cancer

In vitro diagnostic models for ALL: what can we learn on actionable targets?

Transplanting adult ALL patients

Editor's Choice for August 2018

Five practice changing shifts in oncology

Treating myelodysplastic syndromes

Apps and mobile games for the cancer community